Office buildings in Boston, Mass.

| 2 minute read

Breakthrough Properties Fully Leases Boston Building to Biotech Company

BY Lucian Alixandrescu | Jul 31, 2020

Life science real estate investment firm Breakthrough Properties announced the lease of the property at 105 W. First St. in Boston, Mass. to CRISPR Therapeutics, a gene editing company. CRISPR will fully occupy the building, dubbed “The 105,” which totals 263,500 square feet of office space in Boston. Newmark Knight Frank represented the lessor in the lease, while CRISPR was represented by a Cushman & Wakefield team.

The 105 is Breakthrough’s first ground-up development, and was acquired by the company in 2019. The company broke ground on the site in 2020 and the property is scheduled for delivery in early 2022. Designed by architecture firm Payette, the Boston office space is set to benefit from a fitness facility, outdoor terraces and easy access to the MBTA’s Red Line. Breakthrough is also reportedly aiming for a LEED Gold certification.

Dan Belldegrun, CEO of Breakthrough Properties, said: “Our mission at Breakthrough is to deliver cutting edge facilities and environments that support companies at the forefront of life-changing science. We are thrilled to partner with CRISPR, one of the world’s emerging leaders in the biotech industry, as it continues to develop therapies that change the way we fight disease. There has never been a more important time to focus on the scientific innovation and we’re honored to play a small but supportive role in CRISPR’s exciting future.”

Breakthrough Properties was launched in 2019 by Tishman Speyer in conjunction with biotech investment firm Bellco Capital. It aims to acquire, develop and operate state-of-the-art science properties, as well as make investments in agriculture. Tishman Speyer President & CEO, Rob Speyer, said that Breakthrough Properties combines “Tishman Speyer’s global property development capabilities with Bellco Capital’s recognized life sciences expertise and strong relationships.”

CRISPR Therapeutics was founded in 2013 and develops gene-based medicines for serious illnesses. The company also has research and development facilities in Cambridge, Mass., as well as offices in San Francisco, Calif.

Lucian is a senior content writer for CommercialCafe, specializing in commercial real estate research and data-driven reporting since 2019. With deep expertise in industrial real estate, office markets, demographics, and economics, he produces comprehensive market studies and insights on national and regional CRE trends. He also reports on adjacent subjects such as population shifts and the job market. His reports have been cited by and featured in The New York Times, Forbes, NBC, Bisnow, The Business Journals, and Yahoo Finance. Lucian holds a background in language and literature studies and brings more than 5 years of previous freelance writing experience to his commercial real estate journalism.

Recent Reports

Atherton Breaks $10M Median as 11 States Set New Price Records
October 13, 2026

2026 brought record price peaks to 11 states, including the first ever eight-figure median sale price with Atherton’s dramatic surge back to #1. Meanwhile, California’s presence continued to shrink with the pullback of the Bay Area, although it remained home to more than half of the country’s top zips, while the New York metro supplied one quarter, its strongest presence yet.

NYC Homeownership by the Numbers: How Household Type, Gender & Age Shape Who Owns in Every Neighborhood  
August 19, 2026

In a city where homeownership is dominated by married-couple families, Manhattan stands as the only borough led by nonfamily owners. At the same time, residents younger than 35 make up less than one tenth of the ownership pool and female-led family households outnumber male-led families across 91% of NYC neighborhoods.

Prices Rise in 32 of NYC’s Leading Neighborhoods as City and Manhattan Hit Record Highs
July 22, 2026

Q2 2026 saw NYC and Manhattan reach historic highs, with Brooklyn and Queens marking close to new records as well. Meanwhile, Hudson Yards remained at the top, Central Midtown posted its highest price ever and Carroll Gardens marked its third consecutive quarter over $2 million